Jacobs Levy Equity Management Inc. grew its stake in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 37.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,741,306 shares of the company's stock after acquiring an additional 477,634 shares during the period. Jacobs Levy Equity Management Inc. owned 0.70% of Oscar Health worth $23,403,000 at the end of the most recent quarter.
Several other hedge funds have also recently bought and sold shares of OSCR. Barclays PLC lifted its position in Oscar Health by 217.5% during the third quarter. Barclays PLC now owns 325,818 shares of the company's stock worth $6,911,000 after acquiring an additional 223,189 shares during the last quarter. Nordea Investment Management AB acquired a new stake in shares of Oscar Health in the fourth quarter valued at approximately $1,056,000. Harbor Capital Advisors Inc. raised its position in shares of Oscar Health by 39.9% in the fourth quarter. Harbor Capital Advisors Inc. now owns 128,167 shares of the company's stock valued at $1,723,000 after buying an additional 36,577 shares in the last quarter. Hennessy Advisors Inc. raised its position in shares of Oscar Health by 550.3% in the fourth quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company's stock valued at $56,292,000 after buying an additional 3,544,300 shares in the last quarter. Finally, Rolek Wealth Management LLC acquired a new stake in shares of Oscar Health in the fourth quarter valued at approximately $208,000. 75.70% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Separately, Wells Fargo & Company downgraded shares of Oscar Health from an "overweight" rating to an "equal weight" rating and dropped their price target for the company from $20.00 to $16.00 in a research report on Thursday, March 13th. Two research analysts have rated the stock with a sell rating, two have given a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $20.08.
Get Our Latest Stock Analysis on Oscar Health
Insider Activity at Oscar Health
In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the business's stock in a transaction on Monday, May 12th. The stock was sold at an average price of $16.43, for a total transaction of $410,750.00. Following the sale, the director now owns 64,512 shares in the company, valued at $1,059,932.16. The trade was a 27.93% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 24.39% of the stock is currently owned by insiders.
Oscar Health Price Performance
NYSE:OSCR traded up $0.02 during mid-day trading on Thursday, reaching $16.56. The stock had a trading volume of 5,929,517 shares, compared to its average volume of 4,148,641. The stock has a 50-day simple moving average of $13.38 and a two-hundred day simple moving average of $14.64. The stock has a market capitalization of $4.15 billion, a PE ratio of -827.59 and a beta of 1.75. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. Oscar Health, Inc. has a 12 month low of $11.20 and a 12 month high of $23.79.
Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.83 by $0.09. The business had revenue of $3 billion for the quarter, compared to analysts' expectations of $2.87 billion. Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. The firm's quarterly revenue was up 42.2% compared to the same quarter last year. During the same period last year, the firm posted $0.62 earnings per share. On average, equities analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current year.
About Oscar Health
(
Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Featured Stories

Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.